CARLSBAD, Calif.--(BUSINESS WIRE)--While Brendan Technologies, Inc. (OTCBB: BDTE), an innovative analytical software company, is completing the development of its powerful new assay analysis software, STATLIA® Quantum, one of the world’s top ten pharmaceutical companies has already made an advance purchase of the system for one of its worldwide locations. Neither the terms of the agreement nor the company’s name was disclosed.
